ESC 365 - Lifetime Benefits of Combination Therapy in HFpEF

ESC2025 Premium Access

Lifetime Benefits of Combination Therapy in HFpEF

Session: Late-Breaking Clinical Trials: advances in heart failure care

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor M. Vaduganathan (Boston, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Muthiah Vaduganathan

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

39 presentations

13 followers

2 more presentations in this session

LOT-MDR: Loop diuretic dose intensification versus adjuvant thiazide for diuretic resistance in acute heart failure

Speaker: Professor Z. Cox (Nashville, US)

ENVAD-HF: sacubitril/valsartan in Heartmate 3 LVAD recipients

Speaker: Professor M. Cikes (Zagreb, HR)

Access the full session

Late-Breaking Clinical Trials: advances in heart failure care

Speakers: Doctor M. Vaduganathan, Professor Z. Cox, Professor M. Cikes

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources